A prospective, non-interventional study involving the collection of biological samples with associated anonymised data. Biological samples will be collected at the time of diagnosis and/or as the disease progresses, with or without treatment, always in conjunction with tests scheduled as part of routine care or within the context of a clinical trial.
Study Type
OBSERVATIONAL
Enrollment
5,000
Blood samples taken as part of a scheduled assessment within the context of medical care * Standard sample: 2 x 10 mL EDTA tubes * For the initial assessment: 1 x 10 mL dry tube At the request of the research teams: one EDTA tube may be replaced by a heparinised or citrated tube, depending on the planned research. Bone marrow samples, taken during a scheduled myelogram as part of medical care * Myelogram: 1 x 2 mL EDTA tube In exceptional cases, during a scheduled surgical procedure, a tissue sample will be considered in consultation with the surgeon (affected tissue, surrounding healthy tissue).
CHU Amiens Picardie
Amiens, France
Understanding the pathophysiology of chronic myelomonocytic leukaemia
optimise diagnosis, improve prognostic stratification, identify new treatment options and assess patients' response to proposed treatments through the analysis of blood or bone marrow samples collected as part of routine care or clinical trials
Time frame: through study completion, an average of 15 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHU Angers
Angers, France
NOT_YET_RECRUITINGHôpital Privé Antony
Antony, France
NOT_YET_RECRUITINGAP-HP Hôpital Avicenne
Bobigny, France
NOT_YET_RECRUITINGCentre Hospitalier Sud Francilien
Corbeil-Essonnes, France
NOT_YET_RECRUITINGCHU Grenoble
Grenoble, France
NOT_YET_RECRUITINGAP-HP Hôpital Bicêtre
Le Kremlin-Bicêtre, France
NOT_YET_RECRUITINGCHRU Lille Hôpital Claude Huriez
Lille, France
NOT_YET_RECRUITINGCHU Limoges
Limoges, France
NOT_YET_RECRUITINGCHU Nantes
Nantes, France
NOT_YET_RECRUITING...and 14 more locations